IPCA Laboratories quarterly results and financials

IPCA Laboratories (IPCALAB)₹1,960+1.08%(9 Nov 2026 close)Pharmaceuticals

Key facts

In the Jun 2026 quarter (consolidated), IPCA Laboratories reported sales of ₹2,786 Cr, up 20.7% from Jun 2025, and net profit of ₹425 Cr, up 82.0% year on year. For the year to Mar 2026, sales were ₹9,591 Cr and net profit ₹1,186 Cr.

Sales (Jun 2026): ₹2,786 Cr
Net profit (Jun 2026): ₹425 Cr
Sales (FY Mar 2026): ₹9,591 Cr
Net profit (FY Mar 2026): ₹1,186 Cr
EPS (Jun 2026): ₹15.83
Borrowings (Mar 2026): ₹808 Cr

Company filings, consolidated accounts; latest reported quarter Jun 2026

IPCA Laboratories quarterly results

₹ crore unless stated; each column is a quarter.

IPCA Laboratories Quarterly results
	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Sales	2,035	2,054	2,033	2,094	2,354	2,244	2,247	2,309	2,554	2,390	2,386	2,786
Expenses	1,671	1,720	1,710	1,698	1,912	1,779	1,814	1,889	2,010	1,858	1,903	2,117
Operating Profit	361	331	323	393	442	464	430	417	546	533	484	671
OPM %	17.9%	16.0%	15.9%	18.9%	18.9%	20.9%	19.0%	18.0%	20.9%	22.0%	20.0%	23.9%
Other Income	−0.99	90.73	−118	20.95	25.94	19.95	−178	32.92	−29.91	37.88	47.90	24.93
Interest	44.03	33.04	29.04	23.99	23.03	17.01	22.02	19.01	20.02	18.01	20.01	12.01
Depreciation	89.78	99.83	97.90	98.75	99.91	97.82	99.82	99.82	103	108	107	111
Profit before tax	224	288	76.65	289	344	367	128	330	390	444	402	570
Tax %	39.0%	23.0%	96.0%	30.9%	29.0%	24.9%	49.0%	29.0%	27.9%	17.9%	23.9%	26.0%
Exceptional items	−23.99	52.95	−62.91	0.00	0.00	0.00	−116	0.00	−41.95	12.98	−33.99	0.00
Net Profit	136	221	1.01	200	247	276	64.18	234	282	365	308	425
EPS (Rs)	5.71	7.10	2.34	7.57	9.04	9.77	2.68	9.20	11.13	12.87	11.80	15.83

IPCA Laboratories profit and loss

₹ crore unless stated; years end in March. TTM is the last four quarters.

IPCA Laboratories Profit and loss
	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026	TTM
Sales	2,867	3,157	3,259	3,742	4,617	5,396	5,798	6,207	7,661	8,896	9,591	10,116
Expenses	2,568	2,700	2,800	3,045	3,708	3,840	4,464	5,265	6,333	7,152	7,600	7,888
Operating Profit	294	451	455	695	906	1,554	1,327	933	1,327	1,734	1,991	2,235
OPM %	10.0%	14.0%	14.0%	19.0%	19.9%	28.9%	23.0%	15.0%	16.9%	19.0%	21.0%	22.1%
Other Income	20.94	10.98	40.90	55.85	64.87	58.81	53.87	123	16.95	−114	79.83	80.80
Interest	35.01	27.01	28.03	22.01	20.02	12.02	11.01	48.03	141	88.08	79.03	70.05
Depreciation	163	173	178	182	210	209	232	261	357	397	418	428
Profit before tax	116	261	290	544	736	1,384	1,132	742	839	1,127	1,566	1,807
Tax %	17.9%	25.9%	18.0%	18.9%	18.0%	16.9%	20.0%	33.9%	37.0%	30.0%	23.9%	—
Exceptional items	3.99	2.99	4.99	5.99	8.99	5.99	−0.99	16.97	−45.93	−116	−38.98	−62.96
Net Profit	93.22	195	239	443	605	1,143	892	480	525	787	1,186	1,379
EPS (Rs)	3.70	7.70	9.48	17.61	24.01	44.92	34.87	18.59	21.56	29.10	44.99	51.63
Dividend payout %	0.0%	6.0%	5.0%	9.0%	10.0%	9.0%	11.0%	22.0%	19.0%	14.0%	0.0%	—

IPCA Laboratories balance sheet

₹ crore, at each year end.

IPCA Laboratories Balance sheet
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Equity Capital	24.98	24.98	24.96	24.95	24.96	24.94	24.94	24.95	24.95	24.95	24.92	24.93
Reserves	2,178	2,230	2,424	2,657	3,090	3,590	4,663	5,449	5,800	6,286	6,898	8,014
Borrowings	936	868	716	628	465	501	265	807	1,480	1,437	1,363	808
Other Liabilities	672	769	792	803	966	1,135	1,104	1,344	1,306	3,340	3,444	3,491
Total Liabilities	3,811	3,892	3,958	4,114	4,546	5,251	6,058	7,625	8,612	11,089	11,730	12,339
Fixed Assets	1,807	2,021	1,988	1,959	1,948	2,064	2,077	2,425	2,761	4,567	4,280	4,645
CWIP	267	129	94.85	72.93	65.86	133	235	305	140	342	621	771
Investments	15.99	25.99	136	86.95	120	310	505	989	626	863	980	844
Other Assets	1,722	1,716	1,739	1,996	2,412	2,744	3,241	3,906	5,084	5,318	5,849	6,079
Inventories	927	837	882	881	1,072	1,324	1,594	1,857	1,742	2,471	2,558	2,731
Trade receivables	353	446	499	602	681	895	812	910	988	1,685	1,884	2,014
Cash & equivalents	125	176	36.03	151	282	181	365	641	1,853	297	344	565
Total Assets	3,811	3,892	3,958	4,114	4,546	5,251	6,058	7,625	8,612	11,089	11,730	12,339

IPCA Laboratories cash flow

₹ crore, for each year.

IPCA Laboratories Cash flow
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Cash from operating activity	467	708	282	341	500	569	1,089	855	805	945	1,319	1,141
Cash from investing activity	−687	−217	−148	−134	−164	−507	−519	−848	−722	−1,209	−866	−246
Cash from financing activity	252	−464	−160	−130	−184	−137	−307	429	509	−555	−284	−757
Net cash flow	29.06	29.08	−26.05	75.18	153	−76.14	265	433	590	−825	169	142
Capex	676	247	136	137	181	306	362	479	494	411	776	655
Free cash flow	−207	463	147	206	322	277	732	380	347	543	551	486
CFO / OP %	100.0%	251.0%	73.9%	87.9%	88.0%	80.0%	85.9%	80.0%	110.0%	93.9%	96.9%	78.0%

IPCA Laboratories ratios

Working-capital days and returns, by year.

IPCA Laboratories Ratios
	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025	Mar 2026
Debtor days	40	56	57	66	65	70	54	56	57	79	76	76
Inventory days	294	290	291	287	317	295	338	338	277	351	337	354
Days payable	97	145	130	137	154	135	140	101	83	110	111	122
Cash conversion cycle	237	200	218	216	228	229	251	293	251	321	302	308
Working capital days	68	61	74	80	88	88	103	102	71	111	101	109
ROCE %	14.1%	5.0%	9.1%	10.1%	16.1%	19.1%	31.1%	20.1%	11.1%	13.1%	15.1%	17.1%

IPCA Laboratories: frequently asked questions

What are the latest quarterly results of IPCA Laboratories?

For the Jun 2026 quarter, IPCA Laboratories reported sales of ₹2,786 Cr, up 20.7% year on year and net profit of ₹425 Cr, up 82.0% year on year. The operating margin was 23.9%.

What is the annual revenue of IPCA Laboratories?

IPCA Laboratories' sales for the year to Mar 2026 were ₹9,591 Cr; over the last twelve months they were ₹10,116 Cr.

What is the net profit of IPCA Laboratories?

Net profit for the year to Mar 2026 was ₹1,186 Cr, and ₹1,379 Cr over the last twelve months. Earnings per share over the same trailing period were ₹51.63.

How much debt does IPCA Laboratories have?

IPCA Laboratories reported borrowings of ₹808 Cr at Mar 2026, against cash and equivalents of ₹565 Cr.

What is the free cash flow of IPCA Laboratories?

Cash from operations was ₹1,141 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹486 Cr.

Loading…